Future Healthcare: Improving the Effectiveness of the Healthcare System with Existing Resources

Russia needs to create a multi-channel financing model to ensure the sustainability of its healthcare system amidst current resource constraints. Imposing targeted excise taxes on products known to contribute to socially significant diseases could be a fundamental tool and additional source of funding in this regard. International experience has validated this measure as an effective means of curbing the consumption of harmful products. The healthcare system needs to synchronize its fiscal, social, and industrial policies to strike a balance between providing all citizens with access to pharmaceutical therapies, maximizing the economic efficiency of public spending, and fostering the sustainable development of the domestic pharmaceutical industry. What mechanisms for synchronizing fiscal and social measures could facilitate the transition to universal access to drugs? What targeted excise tax rates are economically feasible? How can we ensure a balance between access to innovative drugs and controlling public expenditures when using outcome-based contracting models? What efficacy criteria should be embedded within innovative procurement mechanisms to shift the primary focus from procurement volumes to therapeutic outcomes?